The Chemically-Modified Tetracycline COL-3 and Its Parent Compound Doxycycline Prevent Microglial Inflammatory Responses by Reducing Glucose-Mediated Oxidative Stress

Cells - Tập 10 Số 8 - Trang 2163
Nilson C. Ferreira‐Junior1, Maurício dos Santos Pereira2, Nour Francis1, Paola Ramírez1, Paula Martorell1, Florencia González‐Lizárraga3, Jean Michel Brunel4, Rosana Chehı́n3, Elaine Del‐Bel2, Rita Raisman‐Vozari1, Patrick P. Michel1
1Institut du Cerveau = Paris Brain Institute
2Universidade de São Paulo = University of São Paulo
3Consejo Nacional de Investigaciones Científicas y Técnicas [Buenos Aires]
4Biomolécules : Conception, Isolement, Synthèse

Tóm tắt

We used mouse microglial cells in culture activated by lipopolysaccharide (LPS) or α-synuclein amyloid aggregates (αSa) to study the anti-inflammatory effects of COL-3, a tetracycline derivative without antimicrobial activity. Under LPS or αSa stimulation, COL-3 (10, 20 µM) efficiently repressed the induction of the microglial activation marker protein Iba-1 and the stimulated-release of the pro-inflammatory cytokine TNF-α. COL-3′s inhibitory effects on TNF-α were reproduced by the tetracycline antibiotic doxycycline (DOX; 50 µM), the glucocorticoid dexamethasone, and apocynin (APO), an inhibitor of the superoxide-producing enzyme NADPH oxidase. This last observation suggested that COL-3 and DOX might also operate themselves by restraining oxidative stress-mediated signaling events. Quantitative measurement of intracellular reactive oxygen species (ROS) levels revealed that COL-3 and DOX were indeed as effective as APO in reducing oxidative stress and TNF-α release in activated microglia. ROS inhibition with COL-3 or DOX occurred together with a reduction of microglial glucose accumulation and NADPH synthesis. This suggested that COL-3 and DOX might reduce microglial oxidative burst activity by limiting the glucose-dependent synthesis of NADPH, the requisite substrate for NADPH oxidase. Coherent with this possibility, the glycolysis inhibitor 2-deoxy-D-glucose reproduced the immunosuppressive action of COL-3 and DOX in activated microglia. Overall, we propose that COL-3 and its parent compound DOX exert anti-inflammatory effects in microglial cells by inhibiting glucose-dependent ROS production. These effects might be strengthened by the intrinsic antioxidant properties of DOX and COL-3 in a self-reinforcing manner.

Từ khóa


Tài liệu tham khảo

Pioletti, 2001, Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3, EMBO J., 20, 1829, 10.1093/emboj/20.8.1829

Mortison, 2018, Tetracyclines Modify Translation by Targeting Key Human rRNA Substructures, Cell Chem. Biol., 25, 1506, 10.1016/j.chembiol.2018.09.010

Sapadin, 2006, Tetracyclines: Nonantibiotic properties and their clinical implications, J. Am. Acad. Dermatol., 54, 258, 10.1016/j.jaad.2005.10.004

Bortolanza, 2018, Tetracycline repurposing in neurodegeneration: Focus on Parkinson’s disease, J. Neural. Transm., 125, 1403, 10.1007/s00702-018-1913-1

Orsucci, 2009, Neuroprotective effects of tetracyclines: Molecular targets, animal models and human disease, CNS Neurol. Disord. Drug Targets, 8, 222, 10.2174/187152709788680689

Valentin, 2009, Safety and efficacy of doxycycline in the treatment of rosacea, Clin. Cosmet. Investig. Dermatol., 2, 129

Zhong, 2017, Doxycycline directly targets PAR1 to suppress tumor progression, Oncotarget, 8, 16829, 10.18632/oncotarget.15166

Socias, 2016, Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways, Neurotox. Res., 29, 447, 10.1007/s12640-015-9592-2

Cho, 2009, Doxycycline is Neuroprotective Against Nigral Dopaminergic Degeneration by a Dual Mechanism Involving MMP-3, Neurotox. Res., 16, 361, 10.1007/s12640-009-9078-1

Lazzarini, 2013, Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model, Glia, 61, 1084, 10.1002/glia.22496

Bortolanza, 2021, Doxycycline and its derivative, COL-3, decrease dyskinesia induced by l -DOPA in hemiparkinsonian rats, Br. J. Pharmacol., 178, 2595, 10.1111/bph.15439

Ploper, 2020, CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects, Sci. Rep., 10, 20258, 10.1038/s41598-020-76927-0

Avila, 2017, Repurposing doxycycline for synucleinopathies: Remodelling of α-synuclein oligomers towards non-toxic parallel beta-sheet structured species, Sci. Rep., 7, 41755, 10.1038/srep41755

Medina, 2021, Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity, Front. Aging Neurosci., 13, 635760, 10.3389/fnagi.2021.635760

Golub, 1998, Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms, Adv. Dent. Res., 12, 12, 10.1177/08959374980120010501

Golub, 1999, A chemically modified nonantimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats, Ann. N. Y. Acad. Sci., 878, 290, 10.1111/j.1749-6632.1999.tb07691.x

Syed, 2004, A Phase I and Pharmacokinetic Study of Col-3 (Metastat), an Oral Tetracycline Derivative with Potent Matrix Metalloproteinase and Antitumor Properties, Clin. Cancer Res., 10, 6512, 10.1158/1078-0432.CCR-04-0804

Rudek, 2001, Phase I Clinical Trial of Oral COL-3, a Matrix Metalloproteinase Inhibitor, in Patients with Refractory Metastatic Cancer, J. Clin. Oncol., 19, 584, 10.1200/JCO.2001.19.2.584

Chu, 2007, A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas, Investig. New Drugs, 25, 359, 10.1007/s10637-006-9031-6

Dezube, 2006, Randomized Phase II Trial of Matrix Metalloproteinase Inhibitor COL-3 in AIDS-Related Kaposi’s Sarcoma: An AIDS Malignancy Consortium Study, J. Clin. Oncol., 24, 1389, 10.1200/JCO.2005.04.2614

Zhang, 2011, Role of Matrix Metalloproteinases and Therapeutic Benefits of Their Inhibition in Spinal Cord Injury, Neurotherapeutics, 8, 206, 10.1007/s13311-011-0038-0

Edan, R.A., Luqmani, Y.A., and Masocha, W. (2013). COL-3, a Chemically Modified Tetracycline, Inhibits Lipopolysaccharide-Induced Microglia Activation and Cytokine Expression in the Brain. PLoS ONE, 8.

Zhang, 2005, Aggregated α-synuclein activates microglia: A process leading to disease progression in Parkinson’s disease, FASEB J., 19, 533, 10.1096/fj.04-2751com

Hamadat, 2018, Microglial glutamate release evoked by α-synuclein aggregates is prevented by dopamine, Glia, 66, 2353, 10.1002/glia.23472

Deng, 2021, The efficacy of systemic administration of lipopolysaccharide in modelling pre-motor Parkinson’s disease in C57BL/6 mice, NeuroToxicology, 85, 254, 10.1016/j.neuro.2021.05.015

Ouidja, 2016, A simplified approach for efficient isolation of functional microglial cells: Application for modeling neuroinflammatory responsesin vitro, Glia, 64, 1912, 10.1002/glia.23032

Rousseau, 2013, The Iron-Binding Protein Lactoferrin Protects Vulnerable Dopamine Neurons from Degeneration by Preserving Mitochondrial Calcium Homeostasis, Mol. Pharmacol., 84, 888, 10.1124/mol.113.087965

Pereira, 2021, Contributive Role of TNF-α to L-DOPA-Induced Dyskinesia in a Unilateral 6-OHDA Lesion Model of Parkinson’s Disease, Front. Pharmacol., 11, 617085, 10.3389/fphar.2020.617085

Hoyer, 2002, Dependence of alpha-synuclein ag-gregate morphology on solution conditions, J. Mol. Biol., 322, 383, 10.1016/S0022-2836(02)00775-1

Acuña, L., Hamadat, S., Corbalán, N.S., González-Lizárraga, F., Dos-Santos-Pereira, M., Rocca, J., Díaz, J.S., Del-Bel, E., Papy-García, D., and Chehín, R.N. (2019). Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates. Cells, 8.

Michel, 2020, Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption, Glia, 68, 561, 10.1002/glia.23738

Regen, 2017, A presumed antagonistic LPS identifies distinct functional organization of TLR4 in mouse microglia, Glia, 65, 1176, 10.1002/glia.23151

Qin, 2005, Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation, Glia, 52, 78, 10.1002/glia.20225

Ghosh, 2018, Bioenergetic regulation of microglia, Glia, 66, 1200, 10.1002/glia.23271

Hsieh, 2019, Acute glucose fluctuation impacts microglial activity, leading to inflammatory activation or self-degradation, Sci. Rep., 9, 1, 10.1038/s41598-018-37215-0

Parvathy, 2013, Matrix Metalloproteinase Inhibitor COL-3 Prevents the Development of Paclitaxel-Induced Hyperalgesia in Mice, Med. Princ. Pract., 22, 35, 10.1159/000341710

Meesawatsom, 2020, Spinal neuronal excitability and neuroinflammation in a model of chemotherapeutic neuropathic pain: Targeting the resolution pathways, J. Neuroinflamm., 17, 1, 10.1186/s12974-020-01997-w

Cazalis, 2009, Tetracyclines and Chemically Modified Tetracycline-3 (CMT-3) Modulate Cytokine Secretion by Lipopolysaccharide-Stimulated Whole Blood, Inflammation, 32, 130, 10.1007/s10753-009-9111-9

Fodelianaki, 2019, Nerve Growth Factor modulates LPS—induced microglial glycolysis and inflammatory responses, Exp. Cell Res., 377, 10, 10.1016/j.yexcr.2019.02.023

Gong, 2016, Dexamethasone rapidly inhibits glucose uptake via non-genomic mechanisms in contracting myotubes, Arch. Biochem. Biophys., 603, 102, 10.1016/j.abb.2016.05.020

Patil, 2018, Dexamethasone inhibits inflammatory response via down regulation of AP-1 transcription factor in human lung epithelial cells, Gene, 645, 85, 10.1016/j.gene.2017.12.024

Cantley, 2009, Understanding the Warburg effect: The metabolic requirements of cell proliferation, Science, 324, 1029, 10.1126/science.1160809

Bedard, 2007, The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology, Physiol. Rev., 87, 245, 10.1152/physrev.00044.2005

Taetzsch, 2015, Redox regulation of NF-κB p50 and M1 polarization in microglia, Glia, 63, 423, 10.1002/glia.22762

Tang, 2017, Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation, Mol. Cancer, 16, 1, 10.1186/s12943-017-0607-x

Knudsen, 2019, Cytosolic ROS production by NADPH oxidase 2 regulates muscle glucose uptake during exercise, Nat. Commun., 10, 1

Michalska, 2011, Evaluation of the antioxidant activity of tetracycline antibiotics in vitro, Luminescence, 27, 249

Clemens, D.L., Duryee, M.J., Sarmiento, C., Chiou, A., McGowan, J.D., Hunter, C.D., Schlichte, S.L., Tian, J., Klassen, L.W., and O’Dell, J.R. (2018). Novel Antioxidant Properties of Doxycycline. Int. J. Mol. Sci., 19.

Thông tin
Thông tin xuất bản

Cells

Tập 10 Số 8

2163

Thông tin tác giả